APPLIED THERAPEUTICS INC (APLT)
US03828A1016 - Common Stock
ChartMill assigns a Buy % Consensus number of 87% to APLT. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 7.34. This target is 473.75% above the current price.
APLT was analyzed by 12 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about APLT.
In the previous month the buy percentage consensus was at a similar level.
APLT was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-12-02 | UBS | Downgrade | Buy -> Neutral |
| 2024-11-29 | RBC Capital | Downgrade | Outperform -> Sector Perform |
| 2024-11-29 | Baird | Maintains | Outperform -> Outperform |
| 2024-11-29 | Citigroup | Maintains | Buy -> Buy |
| 2024-09-19 | Leerink Partners | Maintains | Outperform -> Outperform |
| 2024-09-19 | Citigroup | Maintains | Buy -> Buy |
| 2024-08-27 | Citigroup | Maintains | Buy -> Buy |
| 2024-07-31 | William Blair | Initiate | Outperform |
| 2024-07-17 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-04-11 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-03-26 | RBC Capital | Initiate | Outperform |
| 2024-03-15 | UBS | Maintains | Buy -> Buy |
| 2024-03-06 | UBS | Maintains | Buy -> Buy |
| 2024-02-22 | Leerink Partners | Initiate | Outperform |
| 2024-02-16 | Citigroup | Maintains | Buy -> Buy |
| 2023-04-25 | Baird | Maintains | Outperform |
| 2023-04-05 | Citigroup | Maintains | Buy |
| 2022-08-17 | Citigroup | Maintains | Buy |
| 2022-08-16 | Barclays | Maintains | Equal-Weight |
| 2022-05-20 | Citigroup | Maintains | Buy |
| 2022-01-04 | Barclays | Downgrade | Overweight -> Equal-Weight |
| 2021-08-27 | Goldman Sachs | Downgrade | Neutral -> Sell |